News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,291 Results
Type
Article (13586)
Company Profile (110)
Press Release (247595)
Section
Business (87948)
Career Advice (462)
Deals (15324)
Drug Delivery (64)
Drug Development (36530)
Employer Resources (49)
FDA (6259)
Job Trends (6185)
News (150028)
Policy (14007)
Tag
Academia (435)
Alliances (23098)
Alzheimer's disease (352)
Approvals (6254)
Artificial intelligence (61)
Bankruptcy (143)
Best Places to Work (4328)
Biotechnology (44)
Breast cancer (42)
Cancer (315)
Career advice (405)
Cell therapy (44)
Clinical research (30406)
Collaboration (155)
Compensation (62)
COVID-19 (747)
C-suite (52)
Data (346)
Diabetes (53)
Diagnostics (1236)
Drug pricing (57)
Earnings (31560)
Employer resources (43)
Events (36747)
Executive appointments (173)
FDA (6440)
Funding (108)
Gene therapy (59)
GLP-1 (293)
Government (1267)
Healthcare (3522)
Infectious disease (765)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5818)
Job creations (2050)
Job search strategy (372)
Layoffs (167)
Legal (3411)
Lung cancer (46)
Manufacturing (99)
Medical device (1261)
Medtech (1263)
Mergers & acquisitions (9542)
Metabolic disorders (168)
Neuroscience (450)
NextGen Class of 2024 (1580)
Non-profit (590)
Northern California (435)
Obesity (101)
Opinion (109)
Patents (53)
People (28463)
Pharmaceutical (64)
Phase I (7907)
Phase II (12857)
Phase III (11553)
Pipeline (184)
Policy (45)
Postmarket research (1399)
Preclinical (3166)
Radiopharmaceuticals (116)
Rare diseases (90)
Real estate (2629)
Regulatory (9824)
Research institute (563)
Resumes & cover letters (55)
Southern California (436)
Startups (1625)
United States (4301)
Vaccines (112)
Weight loss (78)
Date
Today (32)
Last 7 days (229)
Last 30 days (1245)
Last 365 days (12736)
2024 (11651)
2023 (14244)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (42)
Asia (19794)
Australia (2559)
California (1012)
Canada (605)
China (113)
Colorado (43)
Connecticut (42)
Europe (38783)
Florida (153)
Illinois (111)
Indiana (86)
Japan (43)
Kansas (51)
Maryland (155)
Massachusetts (883)
Minnesota (57)
New Jersey (426)
New York (281)
North Carolina (278)
Northern California (435)
Pennsylvania (288)
South America (498)
Southern California (436)
Texas (141)
Virginia (41)
Washington State (71)
261,291 Results for "iacta pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IACTA Pharmaceuticals to Present at Jefferies Healthcare Conference
IACTA Pharmaceuticals, Inc. (“IACTA”), an innovation leader in ophthalmic therapeutics, today announced that Damon Burrows, Chief Executive Officer, will present at the Jefferies Healthcare Conference on Friday, June 10, 2022 at 8:30 a.m. ET.
June 1, 2022
·
1 min read
Business
IACTA Pharmaceuticals Announces Expansion of Scientific Advisory Board with Two World-Renowned Key Opinion Leaders
IACTA Pharmaceuticals, Inc. (“IACTA”), an innovation leader in ophthalmic therapeutics, today announced the expansion of its Scientific Advisory Board (SAB) with the appointments of Dr. Richard L. Abbott and Dr. Lixin Xie.
June 29, 2022
·
5 min read
Business
IACTA Pharmaceuticals and TALLC Corporation Announce Strategic Collaboration to Utilize Novel SmartCelle Topical Delivery Technology
IACTA Pharmaceuticals, Inc. (“IACTA”), an innovation leader in ophthalmic therapeutics, and TALLC Corporation Inc. (“TALLC”), a pioneering ophthalmology company focused on the growing unmet needs of patients with corneal and retinal conditions, today announced that they are entering into a strategic collaboration and licensing agreement.
December 15, 2021
·
4 min read
Business
IACTA Pharmaceuticals Appoints Yogesh Bahl as Chief Financial Officer and Eric Carter, M.D., Ph.D., as Chief Medical Officer
IACTA Pharmaceuticals, Inc. (IACTA), an innovation leader in ophthalmic therapeutics, today announced the appointment of Yogesh Bahl as Chief Financial Officer (CFO) and Eric Carter, M.D., Ph.D., as Chief Medical Officer (CMO).
July 27, 2021
·
5 min read
Drug Development
IACTA Pharmaceuticals Receives U.S. Department of Defense Funding of $1 Million to Conduct Preclinical Studies of IC 800 to Treat Pain Relief for Eye Injury
IACTA Pharmaceuticals, Inc. today announced that the U.S. Army Medical Research Acquisition Activity (USAMRAA), a division of the Department of Defense, has granted a $1 million award to the company to fund preclinical studies of IC 800
October 28, 2021
·
4 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Press Releases
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
November 14, 2024
·
1 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Press Releases
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
October 28, 2024
·
9 min read
1 of 26,130
Next